Your browser doesn't support javascript.
loading
Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes study.
Bakouny, Z; Labaki, C; Bhalla, S; Schmidt, A L; Steinharter, J A; Cocco, J; Tremblay, D A; Awad, M M; Kessler, A; Haddad, R I; Evans, M; Busser, F; Wotman, M; Curran, C R; Zimmerman, B S; Bouchard, G; Jun, T; Nuzzo, P V; Qin, Q; Hirsch, L; Feld, J; Kelleher, K M; Seidman, D; Huang, H; Anderson-Keightly, H M; El Zarif, T; Alaiwi, S Abou; Champagne, C; Rosenbloom, T D; Stewart, P S; Johnson, B E; Trinh, Q; Tolaney, S M; Galsky, M D; Choueiri, T K; Doroshow, D B.
Affiliation
  • Bakouny Z; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA.
  • Labaki C; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA.
  • Bhalla S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA.
  • Schmidt AL; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA.
  • Steinharter JA; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA.
  • Cocco J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA.
  • Tremblay DA; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA.
  • Awad MM; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA.
  • Kessler A; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA.
  • Haddad RI; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA.
  • Evans M; Department of Medicine, Icahn School of Medicine at Mount Sinai Hospital, New York, USA.
  • Busser F; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA.
  • Wotman M; Department of Medicine, Icahn School of Medicine at Mount Sinai Hospital, New York, USA.
  • Curran CR; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA.
  • Zimmerman BS; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA.
  • Bouchard G; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA.
  • Jun T; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA.
  • Nuzzo PV; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA.
  • Qin Q; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA.
  • Hirsch L; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA.
  • Feld J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA.
  • Kelleher KM; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA.
  • Seidman D; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA.
  • Huang H; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA.
  • Anderson-Keightly HM; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA.
  • El Zarif T; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA.
  • Alaiwi SA; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA.
  • Champagne C; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA.
  • Rosenbloom TD; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA.
  • Stewart PS; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA.
  • Johnson BE; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA.
  • Trinh Q; Division of Urological Surgery, Brigham and Women's Hospital, Boston, USA.
  • Tolaney SM; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA.
  • Galsky MD; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA.
  • Choueiri TK; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA. Electronic address: toni_choueiri@dfci.harvard.edu.
  • Doroshow DB; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA. Electronic address: deborah.doroshow@mssm.edu.
Ann Oncol ; 33(8): 836-844, 2022 08.
Article in En | MEDLINE | ID: mdl-35715285
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 4_TD Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Oncol Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 4_TD Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Oncol Year: 2022 Document type: Article